Literature DB >> 10435489

Penicillamine: the treatment of first choice for patients with Wilson's disease.

J M Walshe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10435489     DOI： 10.1002/1531-8257(199907)14:4<545::aid-mds1001>3.0.co;2-u

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  12 in total

1.  Imaging and Clinical Worsening After Penicillamine Treatment in Wilson's Disease.

Authors:  Hélio A G Teive; Arnolfo de Carvalho; Renato P Munhoz; Adriana Moro; Mariana Moscovich; Egberto Reis Barbosa
Journal:  Mov Disord Clin Pract       Date:  2015-08-16

Review 2.  Diagnosis and treatment of Wilson's disease.

Authors:  Indu Subramanian; Zeba F Vanek; Jeff M Bronstein
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 3.  An overview of the patient with ataxia.

Authors:  Caterina Mariotti; Roberto Fancellu; Stefano Di Donato
Journal:  J Neurol       Date:  2005-05       Impact factor: 4.849

Review 4.  The Pragmatic Treatment of Wilson's Disease.

Authors:  Annu Aggarwal; Mohit Bhatt
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

5.  Penicillamine neurotoxicity: an hypothesis.

Authors:  J M Walshe
Journal:  ISRN Neurol       Date:  2011-07-21

6.  A Case of Wilson's Disease in Patient with Mildly Elevated Liver Enzymes.

Authors:  Young-Hye Cho; Dong-Wook Jeong; Sang-Yeoup Lee; Son-Ki Park; Ki-Tae Yoon; Yun-Jin Kim; Jeong-Ku Lee; Yu-Hyun Lee
Journal:  Korean J Fam Med       Date:  2011-03-31

Review 7.  Molecular mechanism of copper transport in Wilson disease.

Authors:  Negah Fatemi; Bibudhendra Sarkar
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

8.  Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent.

Authors:  Julia Smirnova; Ekaterina Kabin; Ivar Järving; Olga Bragina; Vello Tõugu; Thomas Plitz; Peep Palumaa
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

Review 9.  Advances in Treatment of Wilson Disease.

Authors:  Annu Aggarwal; Mohit Bhatt
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-02-28

10.  Advance in the pathogenesis and treatment of Wilson disease.

Authors:  Qin-Yun Dong; Zhi-Ying Wu
Journal:  Transl Neurodegener       Date:  2012-11-27       Impact factor: 8.014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.